Chiesa G - Search Results

1

A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.

Parolini C, Vik R, Busnelli M, Bjørndal B, Holm S, Brattelid T, Manzini S, Ganzetti GS, Dellera F, Halvorsen B, Aukrust P, Sirtori CR, Nordrehaug JE, Skorve J, Berge RK, Chiesa G. Parolini C, et al. Among authors: chiesa g. PLoS One. 2014 May 19;9(5):e97598. doi: 10.1371/journal.pone.0097598. eCollection 2014. PLoS One. 2014. PMID: 24840793 Free PMC article.

2

Activity profile of gemfibrozil on the major plasma lipoprotein parameters.

Sirtori CR, Franceschini G, Gianfranceschi G, Vaccarino V, Chiesa G, Maderna P, Bertoli M, Calabresi L. Sirtori CR, et al. Among authors: chiesa g. Eur J Epidemiol. 1992 May;8 Suppl 1:120-4. doi: 10.1007/BF00145362. Eur J Epidemiol. 1992. PMID: 1505648 Clinical Trial.

3

Predictability of low-density lipoprotein levels during apheretic treatment of hypercholesterolaemia.

Franceschini G, Busnach G, Calabresi L, Chiesa G, Gianfranceschi G, Zoppi F, Minetti L, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Eur J Clin Invest. 1991 Apr;21(2):209-14. doi: 10.1111/j.1365-2362.1991.tb01811.x. Eur J Clin Invest. 1991. PMID: 1905633

4

Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients.

Franceschini G, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Eur J Clin Invest. 1991 Aug;21(4):384-8. doi: 10.1111/j.1365-2362.1991.tb01385.x. Eur J Clin Invest. 1991. PMID: 1936105

5

Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresis.

Franceschini G, Busnach G, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Am J Med. 1991 May;90(5):633-8. Am J Med. 1991. PMID: 2029022

6

In vitro activity of probucol on cholesteryl ester transport.

Chiesa G, Franceschini G, Sirtori CR. Chiesa G, et al. Biochim Biophys Acta. 1990 Aug 6;1045(3):302-4. doi: 10.1016/0005-2760(90)90135-k. Biochim Biophys Acta. 1990. PMID: 2386803

7

Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.

Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. J Lab Clin Med. 1989 Sep;114(3):250-9. J Lab Clin Med. 1989. PMID: 2504855 Clinical Trial.

8

Effects of probucol on the high density lipoprotein system in hypercholesterolaemic patients.

Franceschini G, Calabresi L, Chiesa G, Vaccarino V, Sirtori M, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Pharmacol Res. 1989 Jan-Feb;21(1):113-4. doi: 10.1016/1043-6618(89)90139-4. Pharmacol Res. 1989. PMID: 2726655 No abstract available.

9

Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.

Franceschini G, Sirtori M, Vaccarino V, Gianfranceschi G, Rezzonico L, Chiesa G, Sirtori CR. Franceschini G, et al. Among authors: chiesa g. Arteriosclerosis. 1989 Jul-Aug;9(4):462-9. doi: 10.1161/01.atv.9.4.462. Arteriosclerosis. 1989. PMID: 2751476 Clinical Trial.

10

Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.

Chiesa G, Michelagnoli S, Cassinotti M, Gianfranceschi G, Werba JP, Pazzucconi F, Sirtori CR, Franceschini G. Chiesa G, et al. Metabolism. 1993 Feb;42(2):229-35. doi: 10.1016/0026-0495(93)90041-l. Metabolism. 1993. PMID: 8474321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page